| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2008, p. 1824-1825, Vol. 46, No. 5
0095-1137/08/$08.00+0 doi:10.1128/JCM.02350-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

and
L. Majoros2*
Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary,1 Department of Medical Microbiology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary,2 Department of Microbiology and Biotechnology, Faculty of Food Science, Corvinus University of Budapest, Budapest, Hungary3
Received 7 December 2007/ Returned for modification 14 January 2008/ Accepted 21 February 2008
A new system, Micronaut-Candida, was compared to API ID32C to identify 264 yeast (Candida albicans, C. parapsilosis, C. tropicalis, C. krusei, C. inconspicua, C. norvegensis, C. lusitaniae, C. guilliermondii, C. dubliniensis, C. pulcherrima, C. famata, C. rugosa, C. glabrata, C. kefyr, C. lipolytica, C. catenulata, C. neoformans, Geotrichum and Trichosporon species, Rhodotorula glutinis, and Saccharomyces cerevisiae) clinical isolates. Results were in concordance in 244 cases. Eighteen out of the 20 of discordant results were correctly identified by Micronaut-Candida but not by API ID32C, as confirmed by PCR ribotyping.
Published ahead of print on 5 March 2008.
Present address: Microbiology Laboratory, Department of Dermatology, Dermatooncology, and Venerology, Semmelweis University, Budapest, Hungary.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|